Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000759

Drug Information
NameRaltitrexed    
SynonymsTomudex, TDX, ZD 1694, Raltitrexed; D 1694; N-(5-(((3,4-Dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl)methylamino)-2-thenoyl)-L-glutamic acid; ZD-1694; AstraZeneca brand of raltitrexed; L-Glutamic acid, N-((5-(((1,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl)methylamino)-2-thienyl)carbonyl)-; 1i00; CPD000469217; SAM001246796; SA-Detection Disk Kit; Bio-0142; 2kce; C21H22N4O6S; Raltitrexed; CHEBI:474007; Raltitrexed (JAN/USAN/INN); 2tsr; CHEBI:41742; CID104758; NSC639186; ZD1694; D16; ZD 1694; SMR000469217; S1192_Selleck; Arkomedika brand of raltitrexed; MLS001424225; (2S)-2-[[5-[methyl-[(2-methyl-4-oxo-1H-quinazolin-6-yl)methyl]amino]thiophene-2-carbonyl]amino]pentanedioic acid; HMS2052I03; ICI D1694; D-1694; Tomudex; KS-5069; D1694; D01064; N-(5-(N-(3,4-Dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino)-2-thenoyl)-L-glutamic acid; DB00293; Tomudex (TN); CHEMBL225071; LS-71840; C068874; AC-19671; ZD-16; 112887-68-0; ZN-D1694; ICI-D1694; NSC-639186; Zeneca brand of raltitrexed; (S)-2-[(1-{5-[Methyl-(2-methyl-4-oxo-3,4-dihydro-quinazolin-6-ylmethyl)-amino]-thiophen-2-yl}-methanoyl)-amino]-pentanedioic acid; ICI-D-1694; AC1L2XFZ; NCI60_013008; C11372    
Trade NameTomudex    
CompanyAstraZeneca    
IndicationColon and rectum cancersApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntineoplastic Agents    
CAS NumberCAS 112887-68-0
FormularC21H22N4O6S    
PubChem Compound IDCID 104758.    
PubChem Substance IDSID 13546.    
SuperDrug ATC IDL01BA03;    
SuperDrug CAS ID112887680;    
TargetThymidylate synthaseInhibitor[2][3]
Ref 1Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. To Reference
Ref 2DNA damage and homologous recombination signaling induced by thymidylate deprivation. Biochem Pharmacol. 2008 Oct 15;76(8):987-96. Epub 2008 Aug 19. To Reference
Ref 3Cellular pharmacology of MTA: a correlation of MTA-induced cellular toxicity and in vitro enzyme inhibition with its effect on intracellular folate and nucleoside triphosphate pools in CCRF-CEM cells. Semin Oncol. 1999 Apr;26(2 Suppl 6):48-54. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543